ETHZilla plans to raise $10 billion through a rights offering to support continued ETH purchases

Huoxun Finance reported on August 23rd that StrategicETHReserve published a post on the X platform stating that ETHZilla (formerly 180 LifeSciences Corp.), a Nasdaq-listed Ethereum treasury company, disclosed that it has amended its previously signed securities sales agreement regarding the issuance of common stock in the prospectus supplement and accompanying prospectus. Under the terms of the amended sales agreement, the company will be able to raise up to US$10,000,000.000 through the issuance and sale of shares of common stock to support its continued purchase of ETH.